XXXinsheng Xie

Xinsheng Xie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xinsheng Xie has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and Imaging Characteristics and Short-Term Outcomes in Patients with Recurrent Varicose Veins: A Single-Center Descriptive Retrospective Study

    by Gang Chen, Yue Lin, Tong Yuan, Ya Peng, Xinsheng Xie, Fanzhen Lv, Xiang Hong, Shichai Hong, Weifeng Lu

    Background: The reported postoperative recurrence rates of lower limb varicose veins differ considerably across studies, ranging from 7% to 62%. This study aimed to characterize the clinical and imaging findings in patients presenting with recurrent varicose veins (RVVs) and to describe short-term clinical outcomes after individualized reintervention. Methods: We enrolled 99 patients (114 lower extremities) with RVVs admitted from January 2018 to June 2025. All patients underwent duplex ultrasound scanning; computed tomography venography or magnetic resonance venography was performed to assess iliac vein anatomy. We analyzed the charts of patients for the prevalence of imaging and clinical abnormalities among patients with RVVs. This study was designed as a descriptive retrospective case series without a non-recurrent control group. We analyzed the distribution of venous abnormalities among the included limbs. Results: The mean patient age was 63.9 ± 9.8 years, and 71.7% of the patients were female. Among the 114 affected limbs, residual great saphenous vein trunks were identified in 55 (48.3%), deep venous reflux in 47 (41.2%), incompetent perforating veins in 7 (6.1%), anterior accessory great saphenous vein reflux in 2 (1.8%), and small saphenous vein reflux in 2 (1.8%). Iliac vein stenosis was suspected in 42 limbs, of which 38 underwent digital subtraction angiography; nonthrombotic iliac vein compression lesions were confirmed in 31 limbs. Confirmed lesions were more frequent in left-sided than right-sided RVVs limbs (35.8% vs. 16.3%; p = 0.03). The median venous clinical severity score decreased from 7 (interquartile range, 5–10) at admission to 2 (interquartile range, 2–3) 6 months after discharge (p < 0.01). All 20 active venous ulcers healed during follow-up. Conclusions: Residual great saphenous vein trunks, deep venous valve insufficiency, and nonthrombotic iliac vein compression lesions were frequently observed venous abnormalities in this retrospective descriptive case series of patients with RVVs. Comprehensive multimodal venous imaging may assist individualized reintervention planning. These findings describe a referred recurrent case series and cannot be interpreted as risk factors for recurrence without a non-recurrent control group. Long-term outcomes require further investigation.

  • Open Access

    Real-World Efficacy of Minimally Invasive Revascularization in Diabetic Foot Ischemia: Impact of Device Selection and Lesion-Specific Factors

    by Yue Lin, Fanzhen Lv, Yulong Huang, Gang Chen, Shichai Hong, Xiang Hong, Xinsheng Xie, Weifeng Lu, Weiguo Fu

    Objectives: The objective of this study was to evaluate the real-world efficacy of minimally invasive revascularization in diabetic foot ischemia, focusing on novel insights into device selection and lesion-specific predictors. Methods: This retrospective study included 98 patients (101 limbs) undergoing endovascular/hybrid interventions. The primary endpoints were 1- and 2-year primary patency and freedom from clinically driven target lesion revascularization (CD-TLR). Multivariate Cox regression identified restenosis predictors, with subgroup analysis comparing drug-coated devices (DCDs) versus conventional strategies in chronic limb-threatening ischemia (CLTI). Results: The cohort (mean age 72.1 ± 8.9 years) comprised 51% CLTI limbs (28.5% with tissue loss). The overall 1-year primary patency was 75.6%, declining to 67.6% after 2 years. The rates of freedom from CD-TLR were 87.4% after 1 year and 74.8% after 2 years. CLTI was associated with significantly reduced 1-year (66.5% vs. 84.9%) and 2-year primary patency (56.3% vs. 80.1%; log-rank p = 0.026) compared to non-CLTI. Multivariate analysis identified CLTI as an independent predictor of restenosis (HR 3.375, 95%CI 1.267–8.990, p = 0.015). Although DCDs did not improve 2-year primary patency in CLTI (58.5% vs. 57.3%, p = 0.768), they demonstrated superior 2-year CD-TLR-free survival (78.5% vs. 54.6%, p = 0.048). The total complication rate was 5.9%, with no significant difference between CLTI and non-CLTI groups (11.5% vs. 0%, p = 0.057). Conclusions: This study highlights CLTI’s impact on revascularization durability and the clinical benefits of DCDs in reducing reinterventions, offering evidence-based insights for tailored device selection despite retrospective limitations.